SCHEMBL15580371

SCHEMBL15580371

c1ccc([C@@H]2CCN[C@H](c3ccccc3)C2)cc1

nearest known ligand 0.57

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
SLC18A3 Q16572 1/20 0.55
SIGMAR1 Q99720 1/20 0.55
KMT2A Q03164 2/20 0.44
MEN1 O00255 1/20 0.44
AKR1C3 P42330 1/20 0.43
AKR1C1 Q04828 1/20 0.43
SLC6A2 P23975 1/20 0.43
CHRNB2 P17787 1/20 0.40
CHRNA4 P43681 1/20 0.40
PRCP P42785 1/20 0.40
MASP2 O00187 1/20 0.39
HPGD P15428 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4237630 1.00 SLC18A3 (0.55) SLC18A3SIGMAR1KMT2AMEN1AKR1C3
SCHEMBL29148914 0.87 SLC18A3 (0.43) SLC18A3SIGMAR1KMT2AMEN1SLC6A2
SCHEMBL30711259 0.86 AKR1C3 (0.44) SLC18A3SIGMAR1AKR1C3AKR1C1SLC6A2
SCHEMBL8129145 0.81 SLC18A3 (0.41) SLC18A3SIGMAR1KMT2AMEN1SLC6A2
SCHEMBL25076786 0.80 GRIN2B (0.47) KMT2AMEN1SLC6A2MASP2HPGD
SCHEMBL29213808 0.80 GRIN2B (0.47) KMT2AMEN1SLC6A2MASP2HPGD
SCHEMBL25076785 0.80 GRIN2B (0.47) KMT2AMEN1SLC6A2MASP2HPGD
SCHEMBL5011948 0.80 SLC18A3 (0.55) SLC18A3SIGMAR1KMT2AAKR1C3AKR1C1
SCHEMBL6072153 0.79 HDAC2 (0.46) SLC18A3SIGMAR1KMT2AMEN1AKR1C3
SCHEMBL24365527 0.78 SLC18A3 (0.39) SLC18A3SIGMAR1KMT2AMEN1CHRNB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2398789-B1 SPIROPYRROLIDINE BETA-SECRETASE INHIBITORS FOR THE TREATMENT OF ALZHEIMER'S DISEASE MERCK SHARP & DOHME (US) 2014-03-19 EP disclosed